Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.615
-0.065 (-2.43%)
Feb 20, 2026, 12:30 PM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $115.81 million as of February 20, 2026. Its market cap has decreased by -12.93% in one year.
Market Cap
115.81M
Enterprise Value
97.18M
1-Year Change
-12.93%
Ranking
Category
Stock Price
$2.62
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $115.81M, a decrease of -18.27%. That is a compound annual growth rate of -6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 118.68M | -27.64% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 115.32M |
| Alpha Cognition | 113.71M |
| Inovio Pharmaceuticals | 111.99M |
| Immunic | 110.34M |
| Codexis | 109.29M |
| Coya Therapeutics | 109.03M |
| Fortress Biotech | 108.63M |
| Korro Bio | 108.11M |